drugset / Trial / NCT02605226
Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer
Unknown
240 enrolled
Tianjin Medical University Cancer Institute and Hospital
Peking University First Hospital · collabShandong Cancer Hospital and Institute · collabShanghai Jiao Tong University School of Medicine · collabSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · collabThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · collabThe Third Xiangya Hospital of Central South University · collabTianjin First Central Hospital · collabXinhua Hospital, Shanghai Jiao Tong University School of Medicine · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This trial is going to evaluate tumor control and quality of life in patients with prostate cancer treated with radiotherapy or cryoablation.
Timeline
- Start
- 2015-11
- Primary completion
- 2017-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Bicalutamide | Other / unclassified | — | Oral |